Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $25.8K |
| Gross profit | — | — | — | $0.00 | $15.6K |
| Gross margin | — | — | — | — | 60.5% |
| Operating income | — | -$1.93M | -$5.22M | — | — |
| Net income | — | $11.5M | $23.9K | -$9.87M | -$12.1M |
| Net margin | — | — | — | — | -46783.1% |
| EPS (diluted) | — | $0.40 | $0.00 | -$8.49 | -$4.79 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | — | -$967K | -$3.11M | -$1.55M | -$6.43M |
| Share buybacks | — | $0.00 | $180M | — | — |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $237M | $239M | $62.7M | $143K | $11.9M |
| Total liabilities | $21.3M | $11.8M | $53.0M | $8.50M | $31.5M |
| Shareholders' equity | -$19.1M | -$9.96M | -$54.8K | -$8.36M | -$19.6M |
| Retained earnings | -$19.1M | -$9.96M | -$9.16M | -$21.7M | -$33.8M |
| Shares (wtd avg diluted) | — | 5.75M | 5.75M | 1.16M | 2.52M |
Every figure is extracted from DevvStream Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.